Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors - Implications for dose-sparing combination therapies.
Rebif approval application
MicroRNAs: The Role in Autoimmune Inflammation.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Multiple Sclerosis: An Update.
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Differences in the burden of psychiatric comorbidity in MS vs the general population.
10 years of interferon beta-1b (Beta feron therapy.
Overview of the immune system.
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
CinnoVex home page
Autoimmune sleep disorders.

Pages